Warby Parker (NYSE:WRBY) Misses Q2 CY2026 Revenue Estimates

Warby Parker (NYSE:WRBY) reported Q2 CY2026 revenue of $235.5 million, up 9.8% year on year, but below analysts’ estimates. Full-year revenue guidance was $967.5 million at the midpoint, about 1.3% under consensus. GAAP EPS of $0.04 matched expectations, and the stock fell 3.4% to $28.29 after the report.

Original reporting
Published Aug 6, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Warby Parker (NYSE:WRBY) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$WRBYBearishMed
01

Why it matters

Traders should weigh the guidance shortfall as the primary negative catalyst, while monitoring whether the margin/EBITDA strength and store growth can translate into improved revenue trajectory in later quarters.

02

Market read

A mixed earnings/guidance update: revenue under consensus and slightly light full-year revenue guidance, but GAAP EPS in line and EBITDA/gross margin beat.

03

What to watch

Store expansion (352 locations, 17.2% average annual growth over two years) and 9.8% YoY Q2 sales growth may indicate demand resilience that could offset the guidance shortfall over subsequent quarters.

Relevance 7/10Novelty 6/10Timing: post-Q2 earnings reaction, stock down 3.4% to $28.29 immediately after reporting

Background

Warby Parker reported Q2 CY2026 results with revenue growth but a miss versus Wall Street expectations, alongside full-year revenue guidance below consensus.

Company-level read

Ticker impact

$WRBYBearishMedium confidence
Context

Warby Parker missed Q2 CY2026 revenue expectations and guided full-year revenue to $967.5M midpoint, 1.3% below estimates.

Expected impact

Likely continued downside or underperformance versus peers until investors focus on margin/EBITDA strength and whether revenue guidance can be revised upward.

Evidence & confidence

Article cites revenue miss and slightly light full-year revenue guidance, while GAAP EPS matched and gross margin/EBITDA outperformed, creating a mixed setup but with guidance shortfall as the key risk.

Market effects

Signals ongoing pressure on consumer discretionary eyewear demand and/or pricing, but also shows retailers can beat margin/EBITDA even when revenue misses.

No specific regional impact described.

No explicit global supply-demand or international catalyst mentioned.

Counterpoint

The revenue miss is relatively small versus guidance and EPS was in line; margin and EBITDA outperformance could support a rebound if investors were overly focused on top-line.

Key entities

  • Warby Parker

    Eyewear retailer reporting Q2 CY2026 revenue miss and full-year revenue guidance of $967.5M midpoint.

Related articles

$WRBYMedAI 8/10

Warby Parker Q2 Earnings Call Highlights

Warby Parker (NYSE:WRBY) reported Q2 retail revenue up 13.6% YoY, with eye exams growing over 30% YoY to about 7% of revenue. E-commerce revenue was $58.7M, down 0.3% YoY. The company reaffirmed FY revenue guidance of $959M to $976M and adjusted EBITDA of $117M to $119M, excluding Intelligent Eyewear.

$WRBYMed

Warby Parker Inc. Q2 2026 Earnings Call Summary

Warby Parker (WRBY) reported 10% Q2 2026 revenue growth, citing strong conversion and record average order values despite softer retail traffic. Eye exam revenue rose 30% YoY to 7% of total business. The company is sunsetting Home Try-On, expanding to 352 stores, and using $11.8M tariff refunds for tech upgrades tied to Intelligent Eyewear. Guidance excludes Intelligent Eyewear revenue and “halo effect” benefits.

$SNDKMed

Futures Flat As Tech Slides After Memory Stocks, Korea Tumble

US stock index futures were mixed, with S&P futures up 0.1% and Nasdaq futures down 0.5% as Sandisk (SNDK) fell about 9% and Western Digital (WDC) about 15% after earnings and weaker memory outlooks. Tech and AI names also dropped on results or guidance misses, while Mag 7 were mixed. Asian markets declined after chip-related losses, and investors awaited US payrolls.

$WRBYMedAI 8/10

Warby Parker Q2 2026 earnings: profit on tariff refund

Warby Parker reported Q2 2026 profit of $4.6M versus a $1.75M loss a year earlier, helped by an $11.8M tariff refund benefit. Revenue rose 9.8% to $235.5M. Gross profit was $136.5M, and full-year net revenue guidance was reaffirmed at $959M to $976M, including $14.4M tariff benefit. The company expects an AI-powered eyewear launch within weeks, with no revenue contribution in guidance.